“Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study” (2016) Bangladesh Journal of Pharmacology, 11(3), pp. 564–569. doi:10.3329/bjp.v11i3.23953.